<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34112128</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>10</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Vaccination coverage estimates and utilization patterns of inactivated enterovirus 71 vaccine post vaccine introduction in Ningbo, China.</ArticleTitle><Pagination><StartPage>1118</StartPage><MedlinePgn>1118</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1118</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-021-11198-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">In China, enterovirus 71 (EV71) is the major etiological agents of hand foot mouth disease that poses severe risks to children's health. Since 2015, three inactivated EV71 vaccines have been approved for use. Previous studies indicated the high willingness of EV71 vaccination in eastern China. However, few studies have assessed coverage and utilization patterns of EV71 vaccine in China.</AbstractText><AbstractText Label="METHODS">Children born during 2012-2018 were sampled and their records were abstracted from Ningbo childhood immunization information management system. Descriptive statistics characterized the study population and assessed coverage and timeliness for EV71 vaccination. Simultaneous administration patterns as well as type of EV71 vaccine used were also evaluated. Bivariate and multivariable analysis was used to examine the relationship of socio-demographic characteristics with vaccination coverage and timeliness.</AbstractText><AbstractText Label="RESULTS">Of 716,178 children living in Ningbo. One hundred seventy-two thousand two hundred thirty-six received EV71 vaccine with a coverage rate of 24.05% and only 8.61% received vaccination timely. 21.97% of children received the complete two dose EV71 series but only 6.49% completed timely. Vaccination coverage and timeliness increased significantly from 2012 birth cohort to 2018 birth cohort. Relatively higher coverage and timeliness were observed in resident children, Inner districts, high socioeconomic areas and large-scaled immunization clinics. Of 329,569 doses of EV71 vaccine, only 5853(1.78%) doses were administered at the same day as other vaccines.</AbstractText><AbstractText Label="CONCLUSIONS">There is a need for increasing EV71 vaccination coverage and timeliness as well as eliminating disparities among different populations. Our study highlights the importance of simultaneous administration to increasing coverage and timeliness of EV71 vaccination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ye</LastName><ForeName>Lixia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ningbo Municipal Center for Disease Prevention and Control, Institute of Immunization and Prevention, Yongfeng Road, Haishu District, Ningbo, 315010, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Jieping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ningbo Municipal Center for Disease Prevention and Control, Institute of Immunization and Prevention, Yongfeng Road, Haishu District, Ningbo, 315010, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Ningbo Municipal Center for Disease Prevention and Control, Institute of Immunization and Prevention, Yongfeng Road, Haishu District, Ningbo, 315010, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ningbo Municipal Center for Disease Prevention and Control, Institute of Immunization and Prevention, Yongfeng Road, Haishu District, Ningbo, 315010, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jianmei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ningbo Municipal Center for Disease Prevention and Control, Institute of Immunization and Prevention, Yongfeng Road, Haishu District, Ningbo, 315010, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Xingqiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Ningbo Municipal Center for Disease Prevention and Control, Institute of Immunization and Prevention, Yongfeng Road, Haishu District, Ningbo, 315010, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Hongjun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Ningbo Municipal Center for Disease Prevention and Control, Institute of Immunization and Prevention, Yongfeng Road, Haishu District, Ningbo, 315010, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Guozhang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ningbo Municipal Center for Disease Prevention and Control, Institute of Immunization and Prevention, Yongfeng Road, Haishu District, Ningbo, 315010, China. nbcdcmianyi@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ppxk2018-10</GrantID><Agency>Ningbo Health Branding Subject Fund</Agency><Country/></Grant><Grant><GrantID>2018A610407</GrantID><Agency>the Science and Technology Planning Project of Ningbo</Agency><Country/></Grant><Grant><GrantID>LGF20H260006</GrantID><Agency>The Public Welfare Technology Application Research Funding Projects of Zhejiang Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coverage</Keyword><Keyword MajorTopicYN="N">Inactivated enterovirus 71 vaccine</Keyword><Keyword MajorTopicYN="N">Simultaneous administration</Keyword><Keyword MajorTopicYN="N">Timeliness</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>11</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34112128</ArticleId><ArticleId IdType="pmc">PMC8194148</ArticleId><ArticleId IdType="doi">10.1186/s12889-021-11198-6</ArticleId><ArticleId IdType="pii">10.1186/s12889-021-11198-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization Western Region . A guide to clinical management and public health response for hand, foot and mouth disease(HFMD) 2011.</Citation></Reference><Reference><Citation>Zheng Y, Jit M, Wu JT, Yang J, Leung K, Liao Q, Yu H. Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China. PLoS One. 2017;12(9):e184266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5608208</ArticleId><ArticleId IdType="pubmed">28934232</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh WM, Badaruddin H, La H, Chen MI, Cook AR. Severity and burden of hand, foot and mouth disease in Asia: a modelling study. BMJ Glob Health. 2018;3(1):e442. doi: 10.1136/bmjgh-2017-000442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2017-000442</ArticleId><ArticleId IdType="pmc">PMC5859810</ArticleId><ArticleId IdType="pubmed">29564154</ArticleId></ArticleIdList></Reference><Reference><Citation>Goksugur N, Goksugur S. Images in clinical medicine. Hand, foot, and mouth disease. N Engl J Med. 2010;362(14):e49. doi: 10.1056/NEJMicm0910628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMicm0910628</ArticleId><ArticleId IdType="pubmed">20375401</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Liu F, Liao Q, Wu P, Chang Z, Huang J, et al. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveill. 2017;22(50):16&#x2013;00824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5743100</ArticleId><ArticleId IdType="pubmed">29258646</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KY. Enterovirus 71 infection and neurological complications. Korean J Pediatr. 2016;59(10):395&#x2013;401. doi: 10.3345/kjp.2016.59.10.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2016.59.10.395</ArticleId><ArticleId IdType="pmc">PMC5099286</ArticleId><ArticleId IdType="pubmed">27826325</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi EJ, Shin YJ, Kim JH, Kim TG, Chang SY. Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res. 2017;6(1):4&#x2013;14. doi: 10.7774/cevr.2017.6.1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert Rev Vaccines. 2016;15(5):599&#x2013;606. doi: 10.1586/14760584.2016.1138862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, Hu Y, Ji T, Song L, Liang Q, Zhang B, Gao Q, Li J, Wang S, Hu Y, Gu S, Zhang J, Yao G, Gu J, Wang X, Zhou Y, Chen C, Zhang M, Cao M, Wang J, Wang H, Wang N. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370(9):818&#x2013;828. doi: 10.1056/NEJMoa1304923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei M, Meng F, Wang S, Li J, Zhang Y, Mao Q, Hu Y, Liu P, Shi N, Tao H, Chu K, Wang Y, Liang Z, Li X, Zhu F. 2-year efficacy, immunogenicity, and safety of Vigoo Enterovirus 71 vaccine in healthy Chinese children: a randomized open-label study. J Infect Dis. 2017;215(1):56&#x2013;63. doi: 10.1093/infdis/jiw502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw502</ArticleId><ArticleId IdType="pubmed">28077584</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, Zhang Y, Li Y, Mao Q, Wang J, Jiang L, Dong C, Che Y, Huang T, Jiang Z, Xie Z, Wang L, Liao Y, Liang Y, Nong Y, Liu J, Zhao H, Na R, Guo L, Pu J, Yang E, Sun L, Cui P, Shi H, Wang J, Li Q. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370(9):829&#x2013;837. doi: 10.1056/NEJMoa1303224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese Center for Disease Control and Prevention Technical guidelines for the use of inactivated enterorus 71 vaccines. Chin J Vaccines Immun. 2016;22(4):458&#x2013;464.</Citation></Reference><Reference><Citation>Guan X, Che Y, Wei S, Li S, Zhao Z, Tong Y, et al. Effectiveness and safety of an inactivated enterovirus 71 vaccine in children aged 6-71 months in a phase IV study. Clin Infect Dis. 2020;71(9):2421&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31734699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, Shi L. A meta-analysis of the acceptance rate of EV71 vaccine among Chinese children's parents in the east. J Trop Med. 2019;19(3):376&#x2013;379.</Citation></Reference><Reference><Citation>Ding K, Yi B, Chen Y, Wang S, Xu G. Attitudes, knowledge of Enterovirus 71 vaccine among parents of children in Ningbo and associated factors. Prev Med. 2017;29(8):850&#x2013;854.</Citation></Reference><Reference><Citation>Qi L, Su K, Xia Y, Tang W, Shen T, Li Q. Enterovirus 71 vaccine acceptance among parents of children &lt; 5 years old and their knowledge of hand, foot and mouth disease, Chongqing, China, 2017. PLoS One. 2019;14(11):e225569. doi: 10.1371/journal.pone.0225569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0225569</ArticleId><ArticleId IdType="pmc">PMC6881008</ArticleId><ArticleId IdType="pubmed">31774839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Meng F, Li J, Li G, Hu J, Cao J, et al. Willingness of parents to vaccinate their 6-60-month-old children with EV71 vaccines: a cross-sectional study in rural areas of northern Jiangsu Province. Hum Vaccin Immunother. 2020:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7482733</ArticleId><ArticleId IdType="pubmed">32209003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Chen Y, Liang H, Wang Y. Routine vaccination coverage of children aged 1-7 years in Zhejiang province, China. Hum Vaccin Immunother. 2018;14(12):2876&#x2013;2883. doi: 10.1080/21645515.2018.1504523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2018.1504523</ArticleId><ArticleId IdType="pmc">PMC6343626</ArticleId><ArticleId IdType="pubmed">30047821</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Liang Z, Zeng J, Zhang J, He P, Su J, Zeng Y, Fan R, Zhao D, Ma W, Zeng G, Zhang Q, Zheng H. Immunogenicity and safety of an inactivated Enterovirus 71 vaccine administered simultaneously with hepatitis B vaccine and group a meningococcal polysaccharide vaccine: a phase 4, open-label, single-center, randomized, Noninferiority Trial. J Infect Dis. 2019;220(3):392&#x2013;399. doi: 10.1093/infdis/jiz129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz129</ArticleId><ArticleId IdType="pubmed">30891604</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W, Zhao Z, Chen J. Birth cohort analysis on inoculation rate of enterovirus 71 vaccine among children at ages of 0 ~ 5 years in Fujian Province,China from 2017 to 2018. Chin J Biol. 2020;33(3):293&#x2013;296.</Citation></Reference><Reference><Citation>Yang F, Liang W, Sun L, Long Y, Zhang M, Li H, Zeng H, Zhen H, Zhen H, Zhu Q. Innoculation of enterorirus 71 vaccine and incidence of hand-foot-mouth disease in Guangdong province. Chin J Public Health. 2020;36(3):351&#x2013;354.</Citation></Reference><Reference><Citation>Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing vaccination: putting psychological science into action. Psychol Sci Public Interest. 2017;18(3):149&#x2013;207. doi: 10.1177/1529100618760521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1529100618760521</ArticleId><ArticleId IdType="pubmed">29611455</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty M, Buchy P, Standaert B, Giaquinto C, Prado-Cohrs D. Vaccine impact: benefits for human health. Vaccine. 2016;34(52):6707&#x2013;6714. doi: 10.1016/j.vaccine.2016.10.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.10.025</ArticleId><ArticleId IdType="pubmed">27773475</ArticleId></ArticleIdList></Reference><Reference><Citation>Azimi P, Keshavarz Z, Cedeno LJ, Allen JG. Estimating the nationwide transmission risk of measles in US schools and impacts of vaccination and supplemental infection control strategies. BMC Infect Dis. 2020;20(1):497. doi: 10.1186/s12879-020-05200-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05200-6</ArticleId><ArticleId IdType="pmc">PMC7351650</ArticleId><ArticleId IdType="pubmed">32652940</ArticleId></ArticleIdList></Reference><Reference><Citation>Habersaat KB, Pistol A, Stanescu A, Hewitt C, Grbic M, Butu C, Jackson C. Measles outbreak in Romania: understanding factors related to suboptimal vaccination uptake. Eur J Pub Health. 2020;30(5):986&#x2013;992. doi: 10.1093/eurpub/ckaa079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckaa079</ArticleId><ArticleId IdType="pmc">PMC7536253</ArticleId><ArticleId IdType="pubmed">32460309</ArticleId></ArticleIdList></Reference><Reference><Citation>Benin AL, Wisler-Scher DJ, Colson E, Shapiro ED, Holmboe ES. Qualitative analysis of mothers' decision-making about vaccines for infants: the importance of trust. Pediatrics. 2006;117(5):1532&#x2013;1541. doi: 10.1542/peds.2005-1728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2005-1728</ArticleId><ArticleId IdType="pubmed">16651306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward PR, Attwell K, Meyer SB, Rokkas P, Leask J. Understanding the perceived logic of care by vaccine-hesitant and vaccine-refusing parents: a qualitative study in Australia. PLoS One. 2017;12(10):e185955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5638294</ArticleId><ArticleId IdType="pubmed">29023499</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaisdell LL, Gutheil C, Hootsmans NA, Han PK. Unknown risks: parental hesitation about vaccination. Med Decis Mak. 2016;36(4):479&#x2013;489. doi: 10.1177/0272989X15607855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0272989X15607855</ArticleId><ArticleId IdType="pubmed">26506958</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendel-Van AJ, Nowak GJ, Aikin AL. What is 'confidence' and what could affect it?: a qualitative study of mothers who are hesitant about vaccines. Vaccine. 2018;36(44):6464&#x2013;6472. doi: 10.1016/j.vaccine.2017.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.09.007</ArticleId><ArticleId IdType="pubmed">28899629</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz CM, Ghirotto L, Sisson H, Sarli L, Artioli G, Bassi MC, Appicciutoli G, Hayter M. A meta-synthesis study of the key elements involved in childhood vaccine hesitancy. Public Health. 2020;180:38&#x2013;45. doi: 10.1016/j.puhe.2019.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2019.10.027</ArticleId><ArticleId IdType="pubmed">31838344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Chen Y, Zhang B, Li Q. An Evaluation of Voluntary Varicella Vaccination Coverage in Zhejiang Province, East China. Int J Environ Res Public Health. 2016;13(6):560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4924017</ArticleId><ArticleId IdType="pubmed">27271649</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Hu Y, Chen Y, Li Q, Xie S. Application of spatial statistics for resource allocation of immunization clinics in Zhejiang Province. Chin J Vaccines Immun. 2016;22(1):41&#x2013;45.</Citation></Reference><Reference><Citation>Boulton ML, Ravi NS, Sun X, Huang Z, Wagner AL. Trends in childhood pneumococcal vaccine coverage in Shanghai, China, 2005-2011: a retrospective cohort study. BMC Public Health. 2016;16:109. doi: 10.1186/s12889-016-2785-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-016-2785-7</ArticleId><ArticleId IdType="pmc">PMC4736258</ArticleId><ArticleId IdType="pubmed">26830912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Chen Y, Guo J, Tang X, Shen L. Completeness and timeliness of vaccination and determinants for low and late uptake among young children in eastern China. Hum Vaccin Immunother. 2014;10(5):1408&#x2013;1415. doi: 10.4161/hv.28054.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.28054</ArticleId><ArticleId IdType="pmc">PMC4896529</ArticleId><ArticleId IdType="pubmed">24584000</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Wu X. Occupational segregation and earnings inequality: rural migrants and local workers in urban China. Soc Sci Res. 2017;61:57&#x2013;74. doi: 10.1016/j.ssresearch.2016.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ssresearch.2016.06.020</ArticleId><ArticleId IdType="pubmed">27886739</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhang T, Wang D. Changes in inequality in utilization of preventive care services: evidence on China's 2009 and 2015 health system reform. Int J Equity Health. 2019;18(1):172. doi: 10.1186/s12939-019-1078-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-019-1078-z</ArticleId><ArticleId IdType="pmc">PMC6849223</ArticleId><ArticleId IdType="pubmed">31711485</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X, Qi X, He H, Zeng Z, Chen E, Li Q, Ding J, Zhu Y. A study on status and standards of human resources of vaccination clinics in Zhejiang Province. Zhejiang J Prev Med. 2014;26(9):905&#x2013;908.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>